PCC0104005

Names

[ Name ]:
PCC0104005

[Synonym ]:
6-{4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy}-2H-1,4-benzoxazin-3(4H)-one hydrochloride (1:1)
2H-1,4-Benzoxazin-3(4H)-one, 6-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-, hydrochloride (1:1)
Brilaroxazine Hydrochloride

Biological Activity

[Description]:

PCC0104005 (PCC-0104005) is a novel modulator of serotonin, dopamine, and noradrenaline receptors, including partial agonism at dopamine D2, D3, D4, serotonin 5-HT1A, and 5-HT2A receptors and antagonism at 5-HT2B, 5-HT6, and 5-HT7 receptors; binds to D2, D3 and D4 with Ki of 0.11, 0.14 and 24 nM, 5-HT2A and 5-HT2B with Ki of 5.1 and 0.34 nM; inhibits 5-HTP-induced head twitches in rats, significantly reduces the escape latency of rats and improved the MK-801-induced memory impairment, improves the recognition disorder induced by MK-801, does not produce catalepsy in mice.

[References]

References 1. Xu Y, et al. Sci Rep. 2018 May 2;8(1):6892. View Related Products by Target Dopamine Receptor

Chemical & Physical Properties

[ Molecular Formula ]:
C₂₂H₂₆Cl₃N₃O₃

[ Molecular Weight ]:
486.819

[ Exact Mass ]:
485.103973

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.